Willingness, Knowledge, Behavior of Vaccination

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 4475

Special Issue Editor


E-Mail Website
Guest Editor
Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland
Interests: willingness; behavior; vaccination; COVID-19

Special Issue Information

Dear Colleagues, 

The 2019 coronavirus disease (COVID-19) has exerted a substantial impact on population health on a global scale. To ameliorate this pandemic, a high uptake rate of its vaccination is crucial. Nevertheless, the percentages of vaccination coverage registered in developed and undeveloped countries in the target vaccination populations (children, adults, high-risk individuals, specific population groups) remain below the recommended levels. Vaccine hesitance, defined as a “delay in acceptance or refusal of vaccines despite availability of vaccine services”, is one of the factors explaining suboptimal percentages of vaccination coverage. High confidence in vaccination programs is necessary to achieve high percentages of vaccination coverage. This Special Issue focuses on the willingness, knowledge, behavior  to increase the percentages of vaccination coverage by means of increasing vaccine confidence. We invite you to share your research, review, or opinion papers in any of these areas, with the hope of bringing more understanding to this ongoing issue and to aid in future vaccine efforts.

Dr. Aneta Nitsch-Osuch
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • willingness
  • behavior
  • vaccination
  • COVID-19

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

14 pages, 997 KiB  
Viewpoint
A Mother’s Dilemma: The 5-P Model for Vaccine Decision-Making in Pregnancy
by Elizabeth Cox, Magali Sanchez, Katherine Taylor, Carly Baxter, Isabelle Crary, Emma Every, Brianne Futa and Kristina M. Adams Waldorf
Vaccines 2023, 11(7), 1248; https://doi.org/10.3390/vaccines11071248 - 17 Jul 2023
Cited by 4 | Viewed by 4161
Abstract
Pregnant women are a highly vaccine-resistant population and face unique circumstances that complicate vaccine decision-making. Pregnant women are also at increased risk of adverse maternal and neonatal outcomes to many vaccine-preventable diseases. Several models have been proposed to describe factors informing vaccine hesitancy [...] Read more.
Pregnant women are a highly vaccine-resistant population and face unique circumstances that complicate vaccine decision-making. Pregnant women are also at increased risk of adverse maternal and neonatal outcomes to many vaccine-preventable diseases. Several models have been proposed to describe factors informing vaccine hesitancy and acceptance. However, none of these existing models are applicable to the complex decision-making involved with vaccine acceptance during pregnancy. We propose a model for vaccine decision-making in pregnancy that incorporates the following key factors: (1) perceived information sufficiency regarding vaccination risks during pregnancy, (2) harm avoidance to protect the fetus, (3) relationship with a healthcare provider, (4) perceived benefits of vaccination, and (5) perceived disease susceptibility and severity during pregnancy. In addition to these factors, the availability of research on vaccine safety during pregnancy, social determinants of health, structural barriers to vaccine access, prior vaccine acceptance, and trust in the healthcare system play roles in decision-making. As a final step, the pregnant individual must balance the risks and benefits of vaccination for themselves and their fetus, which adds greater complexity to the decision. Our model represents a first step in synthesizing factors informing vaccine decision-making by pregnant women, who represent a highly vaccine-resistant population and who are also at high risk for adverse outcomes for many infectious diseases. Full article
(This article belongs to the Special Issue Willingness, Knowledge, Behavior of Vaccination)
Show Figures

Figure 1

Back to TopTop